Drug Shortage Report for PRALUENT
| Report ID | 137220 |
| Drug Identification Number | 02453835 |
| Brand name | PRALUENT |
| Common or Proper name | Praluent |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALIROCUMAB |
| Strength(s) | 150MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 2 |
| ATC code | C10AX |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2021-04-29 |
| Actual start date | |
| Estimated end date | 2021-05-14 |
| Actual end date | 2021-05-03 |
| Shortage status | Resolved |
| Updated date | 2021-05-04 |
| Company comments | A manufacturing delay may create a short term shortage. Supplies are expected by early May, shortage should be avoided as allocation will be put in place. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: [email protected] Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2021-05-04 | French | Compare |
| v6 | 2021-05-04 | English | Compare |
| v5 | 2021-04-30 | English | Compare |
| v4 | 2021-04-09 | French | Compare |
| v3 | 2021-04-09 | English | Compare |
| v2 | 2021-04-09 | French | Compare |
| v1 | 2021-04-09 | English | Compare |
Showing 1 to 7 of 7